ArticleTranslational lung cancer research2025

Treatment outcome and safety of durvalumab after concurrent chemoradiation in very elderly patients with unresectable stage III non-small cell lung cancer.

So Jeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.